The PatchServer brings automation to the classical patch clamp method.
Its unique pipette-based approach excels in high quality gigaseals, visual cell selection and fast compound application.
The PatchServer originated in 2008 as a research project of our electrophysiology group at NMI TT Pharmaservices to develop an automated patch clamp system for ultra fast compound applications and stem cell research.
Optical selection of the cells to be patch clamped
Fast compound application in the ms-range
Currently, the PatchServer is actively developed and used for drug screening and safety pharmacology.
A commercial version of the PatchServer is also beeing independently developed by Multichannel Systems GmbH (MCS). For more information, see the MCS PatchServer product page.